Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/65649
Title: Immunome and immune complex-forming components of Brugia malayi identified by microfilaremic human sera
Authors: Onrapak Reamtong
Kitiya Rujimongkon
Nitat Sookrung
Atiporn Saeung
Tipparat Thiangtrongjit
Yuwaporn Sakolvaree
Suwich Thammapalo
Sumat Loymek
Wanpen Chaicumpa
Keywords: Immunology and Microbiology
Medicine
Issue Date: 1-May-2019
Abstract: © 2019 Adult Brugia malayi proteins with high potential as epidemiological markers, diagnostic and therapeutic targets, and/or vaccine candidates were revealed by using microfilaremic human sera and an immunoproteomic approach. They were HSP70, cytoplasmic intermediate filament protein, independent phosphoglycerate mutase, and enolase. Brugia malayi microfilaria-specific proteins that formed circulating immune complexes (ICs)were investigated. The IC-forming proteins were orthologues of hypothetical protein Bm1_12480, Pao retrotransposon peptidase family protein, uncoordinated protein 44, NAD-binding domain containing protein of the UDP-glucose/GDP-mannose dehydrogenase family which contained ankyrin repeat region, ZU5 domain with C-terminal death domain, C2 domain containing protein, and FLJ90013 protein of the eukaryotic membrane protein family. Antibodies to these proteins were not free in the microfilaremic sera, raising the possible role of the IC-forming proteins in an immune evasion mechanism of the circulating microfilariae to avoid antibody-mediated-host immunity. Moreover, detection of these ICs should be able to replace the inconvenient night blood sampling for microfilaria in an evaluation of efficacy of anti-microfilarial agents.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064759898&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/65649
ISSN: 10902449
00144894
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.